Announced
Completed
Synopsis
Cobepa, a private equity firm, completed an investment in Reaction Biology, a provider of drug discovery services. Financial terms were not disclosed. "With John's deep experience growing life sciences companies, we believe this partnership will bring significant benefit to Reaction's customers, employees, and investors alike," Peter Connolly, Cobepa Managing Director.
Principals
Show Details & Financials
Did you work on this deal?
Showcase your expertise to over 3 million dealmakers and industry leaders on Datasite.
Sort
Search a database of more than 250,000 verified dealmakers
Receive automated updates on global transactions
Follow the activity, relationships and transactions of top dealmakers
© COPYRIGHT 2024 MERGERLINKS LIMITED.
ALL RIGHTS RESERVED.
15 BONHILL STREET, LONDON, EC2A 4DN, UNITED KINGDOM.